Select Publications
Journal articles
2010, 'The risk of psychotic symptoms associated with recreational methamphetamine use', Drug and Alcohol Review, 29, pp. 358 - 363, http://dx.doi.org/10.1111/j.1465-3362.2009.00160.x
,2009, 'The Validity of Street Terms Used to Monitor the Australian Methamphetamine Market', The Open Addiction Journal, 2, pp. 30 - 33, http://dx.doi.org/10.2174/1874941000902010030
,2009, 'A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence', Addiction, 104, pp. 224 - 233, http://dx.doi.org/10.1111/j.1360-0443.2008.02437.x
,2009, 'Mechanisms underlying aggressive and hostile behavior in amphetamine users', Current Opinion in Psychiatry, 22, pp. 269 - 273
,2009, 'Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia', Drug and Alcohol Review, 28, pp. 592 - 599, http://dx.doi.org/10.1111/j.1465-3362.2008.00016.x
,2009, 'The holy grail of supply control: Have we found the evidence?', Addiction, 104, pp. 455 - 456
,2009, 'The market for crystalline methamphetamine in Sydney, Australia', Global Crime, 10, pp. 113 - 123
,2008, 'Illicit drug trends globally', , pp. 515 - 523, http://dx.doi.org/10.1016/B978-012373960-5.00354-3
,2008, 'Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants', Drug and Alcohol Review, 27, pp. 277 - 285, http://dx.doi.org/10.1080/09595230801919486
,2008, 'Hostility among methamphetamine users experiencing psychotic symptoms', American Journal on Addictions, 17, pp. 235 - 240, http://dx.doi.org/10.1080/10550490802019816
,2008, 'Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use', Drug and Alcohol Review, 27, pp. 482 - 489
,2008, 'Major physical and psychological harms of methamphetamine use', Drug and Alcohol Review, 27, pp. 253 - 262, http://dx.doi.org/10.1080/09595230801923702
,2008, 'Methamphetamine precursor regulation: are we controlling or diverting the drug problem?', Addiction, 103, pp. 521 - 523
,2008, 'Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology', Addiction, 103, pp. 1353 - 1360
,2008, 'The rise of methamphetamine in southeast and East Asia', Drug and Alcohol Review, 27, pp. 220 - 228, http://dx.doi.org/10.1080/09595230801923710
,2007, 'Hospital seperation for cannabis- and methamphetamine-related psycholtic episodes in Australia', Medical Journal of Australia, 186, pp. 342 - 345
,2007, 'Methamphetamine and cardiovascular pathology: a review of the evidence', Addiction, 102, pp. 1204 - 1211
,2007, 'Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia', Drug and Alcohol Review, 26, pp. 161 - 168
,2006, 'The relationship between crystalline methamphetamine use and methamphetamine dependence', Drug and Alcohol Dependence, 85, pp. 198 - 204, http://dx.doi.org/10.1016/j.drugalcdep.2006.04.007
,2006, 'Methods estimating the prevalence of problem drug use', International Journal of Drug Policy, 17, pp. 154 - 158
,2006, 'The prevalence of psychotic symptoms among methamphetamine users', Addiction, 101, pp. 1471 - 1478
,2005, 'A common language for a common problem: The developing role of drug epidemiology in a global context', , pp. 161 - 176, http://dx.doi.org/10.1007/0-387-24416-6_11
,2005, 'Use of archival data', , pp. 63 - 78, http://dx.doi.org/10.1007/0-387-24416-6_5
,2005, 'Characteristics of treatment provided for amphetamine use in New South Wales, Australia', Drug and Alcohol Review, 24, pp. 433 - 436
,2005, 'Recent trends in heroin supply to markets in Australia, the United States and Western Europe', International Journal of Drug Policy, 16, pp. 293 - 299, http://dx.doi.org/10.1016/j.drugpo.2005.07.001
,2004, 'The effects of restricting publicly subsidised temazepamcapsules on benzodiazepine use among injecting drug users in Australia', Medical Journal of Australia, 181, pp. 300 - 304
,2003, 'Developing a global perspective on drug information systems', Drug and Alcohol Review, 22, pp. 387 - 389, http://dx.doi.org/10.1080/09595230310001613895
,2003, 'Developing a global perspective on drug consumption patterns and trends- the challenge for drug epidemiology', Bulletin on Narcotics, LV, pp. 1 - 8
,2003, 'Supporting evidence-based policy-making : a case study of the Illicit Drug Reporting System in Australia', Bulletin on Narcotics, LV,, pp. 23 - 30
,2002, 'Estimating the prevalence of problematic drug use: A review of methods and their application', Bulletin on Narcotics, 54, pp. 15 - 32
,2000, 'The illicit drugs reporting system.', N S W Public Health Bull, 11, pp. 49 - 52, http://dx.doi.org/10.1071/nb00025
,1999, 'Use of RAM to monitor illicit drug use in developed countries: can rapid assessment result in a rapid response?', DRUG AND ALCOHOL REVIEW, 18, pp. 333 - 335, http://dx.doi.org/10.1080/09595239996491
,1999, 'Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans', Neuropsychopharmacology, 21, pp. 380 - 390
,1999, 'Event-related potential indices of auditory selective attention in dependent amphetamine users', Biological Psychiatry, pp. 1488 - 1497
,1998, 'Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls', Drug and Alcohol Dependence, pp. 181 - 184
,1997, 'Attention and memory in illicit amphetamine users', Drug and Alcohol Dependence, pp. 235 - 242
,Conference Papers
2024, 'OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM', in Drug and Alcohol Dependence, Elsevier BV, pp. 110067 - 110067, http://dx.doi.org/10.1016/j.drugalcdep.2023.110067
,2021, 'COVID AND THE LIMA STUDY, A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S12 - S13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'FINDINGS OF THE N-ICE STUDY: A RANDOMISED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF N-ACETYL CYSTEINE AS A PHARMACOTHERAPY FOR METHAMPHETAMINE DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S105 - S106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200258&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'PREDICTING REDUCTIONS IN METHAMPHETAMINE USE IN THE N-ICE TRIAL: A RANDOMISED CONTROLLED TRIAL OF N-ACETYL CYSTEINE FOR METHAMPHETAMINE DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S12 - S12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'PATTERNS OF HEALTH SERVICE UTILISATION IN A COHORT OF CHRONIC METHAMPHETAMINE USERS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 55 - 55, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'PREDICTING ABSTINENCE FROM METHAMPHETAMINE USE AFTER RESIDENTIAL REHABILITATION', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 46 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'INTERVENTIONS FOR PSYCHOSTIMULANT USE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'THE STIMULANT TREATMENT PROGRAM EVALUATION: CLIENT CHARACTERISTICS AND PRELIMINARY OUTCOMES', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A70 - A70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Impact of illicit amphetamine use on neuropsychological functioning', in Harris L (ed.), Problems of Drug Dependence, pp. 104 - 104, presented at Problems of Drug Dependence, 14 June 1997 - 19 June 1997
,Conference Posters
2021, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
,2020, 'Trends in methamphetamine availability, use, and harms in Australia', presented at The 2020 NDARC Annual Research Symposium, 05 November 2020 - 26 November 2020, https://ndarc.med.unsw.edu.au/resource/trends-methamphetamine-harms-australia
,Conference Presentations
2024, 'Influences of methamphetamine use on family relationships: Interviews with family members', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=5s
,2024, 'We need to talk about contingency management', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=7YQqzJTbdAs&t=2652s
,2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
,